MOCT:用于协同药物组合预测的多类斜树算法
IEEE transactions on computational biology and bioinformatics
|December 18, 2025
概括
这项研究引入了一种基于集群的曲决策树 (MOCT) 算法,用于药物组合预测. MOCT有效地处理了阶级不平衡,并提高了用于生物和医学应用的模型解释性.
科学领域:
- 计算生物学是一种计算生物学.
- 机器学习是机器学习.
- 药理学 药理学是指药理学的学科.
背景情况:
- 机器学习模型越来越多地用于药物组合预测.
- 阶级不平衡和缺乏可解释性是当前预测模型的重大挑战.
- 现有的方法很难在复杂的生物数据集中有效解决这些问题.
研究的目的:
- 提出一个新的基于集群的斜决策树 (MOCT) 算法.
- 从多类数据集中提取可解释的知识,特别是用于药物组合预测.
- 解决传统方法在处理类不平衡和确保模型可解释性方面的局限性.
主要方法:
- 开发了一个基于集群的斜决策树 (MOCT) 算法.
- 实施了分层聚类方法,按类别分组样本.
- 为数据分割和节点创建生成特征子空间,优化可解释性和简洁性.
- MOCT每层只生长一个非叶节点,确保了紧的树结构.
主要成果:
- 与其他方法相比,MOCT算法在药物组合预测任务中表现优越.
- 提出的方法有效地处理了与生物数据集固有的阶级不平衡问题.
- 来自三个细胞系的实验结果显示,模型的解释性得到了增强,这对于生物学和医学专家来说至关重要.
结论:
- MOCT算法为药物组合预测提供了强大的解决方案,特别是在有阶级失衡的场景中.
- MOCT的可解释性促进了对临床应用的预测模型的更好理解和信任.
- 这种方法通过提供可解释和准确的预测,促进了机器学习在精密医学中的应用.
相关概念视频
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Bioequivalence of Drugs: Drugs with Multiple Indications
141
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
141
Combined Effects of Drugs: Antagonism
11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Agonism and Antagonism: Quantification
942
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
942
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K


